Anti-DPT/TRAMP antibody [EPR22845-83]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Rabbit Recombinant Monoclonal DPT/TRAMP antibody. Suitable for WB and reacts with Human, Mouse, Rat samples. Cited in 3 publications.
View Alternative Names
Dermatopontin, Tyrosine-rich acidic matrix protein, TRAMP, DPT
- WB
Supplier Data
Western blot - Anti-DPT/TRAMP antibody [EPR22845-83] (AB255823)
Blocking and Dilution Buffer and concentration : 5% NFDM/TBST.
This blot was developed using a higher sensitivity ECL substrate. There is weak expression in human testis, liver and pancreas. The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 10233760, 8082810).
Exposure time : 125 seconds
All lanes:
Western blot - Anti-DPT/TRAMP antibody [EPR22845-83] (ab255823) at 1/1000 dilution
Lane 1:
Human testis lysate at 20 µg
Lane 2:
Human liver lysate at 20 µg
Lane 3:
Human pancreas lysate at 20 µg
Secondary
All lanes:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
Predicted band size: 24 kDa
Observed band size: 22 kDa
false
- WB
Supplier Data
Western blot - Anti-DPT/TRAMP antibody [EPR22845-83] (AB255823)
The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 10233760 and 8082810).
Negative control : HepG2 (PMID : 19916908).
Exposure time :
Lanes 1-3 : 15 seconds; Lanes 4 : 59 seconds
All lanes:
Western blot - Anti-DPT/TRAMP antibody [EPR22845-83] (ab255823) at 1/1000 dilution
Lane 1:
Human skin lysate at 20 µg
Lane 2:
HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3:
Rat skin lysate at 20 µg
Lane 4:
Mouse skin lysate at 20 µg
Secondary
All lanes:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/100000 dilution
Predicted band size: 24 kDa
Observed band size: 22 kDa
false
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Dermatopontin contributes to maintaining dermal structural integrity and facilitating wound healing. As part of a larger protein interaction network it enhances cellular communication and tissue repair processes. Dermatopontin modulates the bioavailability of TGF-beta which is essential for collagen production and tissue homeostasis. This highlights its presence in skin remodeling and repair mechanisms linking it to new tissue formation.
Pathways
Dermatopontin participates actively in the TGF-beta signaling pathway and the ECM-receptor interaction pathway. These pathways are critical for cellular communication and tissue structuring processes. The protein interacts with Integrins and Fibronectin facilitating cell-to-ECM adhesion and remodeling activities. Consequently Dermatopontin's pathway involvement supports dynamic tissue responses such as healing and functional adaptation to environmental changes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Science advances 11:eadw5133 PubMed40737399
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 14:106 PubMed36774339
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of Cancer 11:6288-6298 PubMed33033513
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com